Viitar is a strategic advisor and execution partner helping biotech, biomedical, IVD, and medical device companies grow through business development, sales & marketing, and overseas presence setup.
Viitar bridges the gap between biotech innovation and global market success. We serve as the strategic and operational arm for companies that want to grow, expand, and compete internationally.
With deep domain expertise across IVD, diagnostics, medical devices, and biomedical solutions, we bring the networks, the market intelligence, and the execution capabilities your business needs — whether that means entering China, establishing a Singapore hub, or expanding across APAC and the Americas.
From market entry strategy to full commercial execution — we cover every stage of your growth journey.
Identifying and structuring partnerships, distribution agreements, and licensing deals across your target markets.
Building awareness, generating leads, and converting opportunities in highly specialised biotech and medtech markets.
Setting up local presence, navigating regulatory requirements, and building the infrastructure for sustainable expansion.
Providing senior-level guidance on portfolio direction, commercial positioning, and investment readiness for life sciences companies.
Viitar works with a select portfolio of biotech, diagnostic, and medtech companies across different product categories. Portfolio company identities are kept confidential — engagements shared with qualified partners upon request.
A comprehensive in-vitro diagnostic platform for food allergy testing and environmental sensitivity screening. Covers 200+ IgE and IgG markers from a minimal blood sample using advanced biochip technology.
A next-generation orthopaedic short arm cast produced via proprietary 4D printing technology. Lightweight, breathable, waterproof, and custom-moulded — a significant advancement over traditional fibre-glass solutions.
A certified diagnostic standard and quality control kit based on human blood serum. Designed for IVD manufacturers and laboratory accreditation, ensuring accurate calibration and reproducibility for clinical testing.
Strategic regulatory consulting for medical device and IVD registration across US FDA, CE mark, NMPA (China), HSA (Singapore), and TFDA (Taiwan). End-to-end documentation, submission support, and timeline management.
Supporting biotech and medtech companies with clinical trial strategy, CRO selection, protocol design, site management, and regulatory submission. Enabling faster, more cost-effective pathways to clinical evidence.
A cloud-based health data platform integrating patient monitoring, wearable connectivity, and AI-driven diagnostic decision support. Enabling clinicians and patients with actionable, real-time health intelligence.
Next-generation sequencing platforms and genomic profiling solutions for oncology, rare disease, and pharmacogenomics applications. Enabling personalised treatment decisions backed by molecular evidence.
Viitar is actively onboarding new portfolio partners across regenerative medicine, point-of-care diagnostics, and pharmaceutical distribution.
Enquire NowConfidentiality Notice: Portfolio company identities and specific partnership details are kept confidential. Engagements and company names are shared with qualified partners upon request. Contact sales@viitar.com to learn more.
From Singapore to South America — Viitar opens doors across the most important life sciences markets globally.
We combine domain expertise with operational depth to deliver measurable commercial outcomes for life sciences companies.
Our team brings 20+ years of hands-on experience in IVD, diagnostics, medical devices, and biomedical R&D.
Direct access to hospital decision-makers, KOLs, distributors, and regulatory bodies across 8+ markets.
We understand both Western and Asian business cultures — bridging the gap for seamless international expansion.
Leveraging existing networks and proven market entry frameworks to significantly reduce your time-to-revenue.
In-depth knowledge of FDA, CE, NMPA, HSA, and TFDA pathways — ensuring compliant and efficient market access.
Our compensation and engagement models are aligned with your success — we win when you win.
Ready to explore how Viitar can accelerate your commercial strategy? Drop us a message and we'll respond within 1 business day.